By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Affitech A/S 

Oslo Research Park
Gaustadalléen 21
Oslo    N-0349  Norway
Phone: 47-22-95-87-58 Fax: 47-22-95-83-58




Company News
Affitech A/S Release: Due Date Extended for Short Term Loan Provided by Trans Nova 10/12/2012 9:34:05 AM
The Delisting of Affitech A/S is Suspended by NASDAQ OMX Copenhagen A/S 10/11/2012 9:31:25 AM
GE Healthcare Life Sciences Executes Recombinant Protein License from Affitech A/S 10/17/2011 10:29:04 AM
Selexis SA CEO Elected to Board of Affitech A/S 7/13/2011 6:31:48 AM
Avid Bioservices, Inc. Secures Biomanufacturing Contract With Affitech AS 9/30/2010 9:03:46 AM
Peregrine Pharmaceuticals, Inc. (PPHM) and Affitech AS to Amend License Agreements to Expedite Development of Novel Fully Human Anti-VEGF Antibody AT001/R84 9/30/2010 9:01:07 AM
Affitech AS Appoints Dr. Robert Burns as CEO 9/1/2009 6:53:35 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Licenses Anti-VEGF Antibodies to Affitech AS 7/22/2009 7:51:25 AM
Affitech AS-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals, Inc. (PPHM) Show Excellent Functionality in Preclinical Studies 4/28/2009 8:56:31 AM
Affitech AS Strengthens Patent Position on its Phagemid Antibody Screening Technology in Europe 4/2/2009 8:56:47 AM